ALL MARKETS
FTSE 100
FTSE 250
AIM MARKET

Angle.
30 announcements.
Time Date Ticker Company Announcement
07:00 28-04-2025 AGL Angle
RESULTS SUPPORTING ANGLE’S HER2 ASSAY PROGRAMME
07:00 21-03-2025 AGL Angle
Issue of LTIP Options and Share Options
07:00 21-03-2025 AGL Angle
Results of Eisai Phase 2 pilot study
07:00 06-02-2025 AGL Angle
Novel findings using Parsortix
07:00 29-01-2025 AGL Angle
Analysis of CTC-DNA and ctDNA using Illumina assay
10:05 24-01-2025 AGL Angle
Parsortix used in research paper from ETH Zurich
07:00 23-01-2025 AGL Angle
Trading Update
08:43 13-12-2024 AGL Angle
HER2 presentation at SABCS
07:00 26-09-2024 AGL Angle
Half-year Report
07:00 23-09-2024 AGL Angle
Exclusive agreement for DNA NGS panel
07:00 17-09-2024 AGL Angle
Notice of Interim Results and Webcast
15:07 11-07-2024 AGL Angle
Result of 2024 Annual General Meeting
07:00 21-06-2024 AGL Angle
Result of open offer
14:41 18-06-2024 AGL Angle
Posting of 2023 Annual Report & Notice of the AGM
16:37 06-06-2024 AGL Angle
Publication of Circular
16:04 05-06-2024 AGL Angle
Results of placing and subscription
07:00 05-06-2024 AGL Angle
Proposed Placing, Subscription and Open Offer
07:00 05-06-2024 AGL Angle
Preliminary Results
07:00 03-05-2024 AGL Angle
New commercial agreement with large pharma
07:00 24-04-2024 AGL Angle
New commercial agreement with AstraZeneca
07:00 22-04-2024 AGL Angle
US and EU patents for innovative CellKeep™ slide
07:00 04-01-2024 AGL Angle
Breakthrough clinical results
07:00 02-01-2024 AGL Angle
Contract announcement with Eisai Inc.
07:00 11-12-2023 AGL Angle
Broker Announcement
07:00 09-11-2023 AGL Angle
Trading and business update
07:00 07-09-2023 AGL Angle
Interim Results for the period ended 30 June 2023
07:00 15-08-2023 AGL Angle
ANGLE notice of interim results
16:54 28-06-2023 AGL Angle
Result of 2023 Annual General Meeting
07:00 25-05-2023 AGL Angle
Pharma services contract with Artios Pharma
07:00 22-05-2023 AGL Angle
Board change - appointment of new Chairman